Pharmacy Benefit Managers Oversee Prescription Drug Plans to Over 200 Million Americans

Research and Markets (http://www.researchandmarkets.com/reports/c31478) has announced the addition of Pharmacy Benefit Management Market Overview to their offering.

Pharmacy benefit managers (PBMs) organize the market for prescription drugs. Pharmacy benefit managers secure deep discounts from drug manufacturers and retail pharmacies for large employers or health plans. They try to influence doctors’ prescribing habits and encourage the use of lower-cost drugs, including generic substitutes for brand-name medicines. They strongly recommend certain drugs over others in each therapeutic category. PBMs administer prescription drug plans for more than 200 million Americans with drug coverage provided through the nation’s small and large employers, Taft-Hartley union plans, health insurers, state and federal-employee benefit plans, Medicare Advantage health plans, and state Medicaid plans. Mergers have nearly cut the number of PBMs in half, from more than 100 five years ago to about 55 today. The largest of the recent mergers consolidated Caremark Rx with AdvancePCS. Although the top five PBMs have a market share of nearly 60% when measured by number of covered lives, there are a number of smaller market players that are having a significant impact on the market place. Industry consolidation is likely to continue over the next few years. Our Pharmacy Benefit Management Market Overview, 300 pages in length, provides insight into the trends and issues affecting the market. Our Pharmacy Benefit Management Market Overview also identifies more than 50 of the leading market participants and provides a brief profile on each company, which includes (when available): the company background, strategy, products and services, financial and statistical information, and recent activities.

This Pharmacy Benefit Management Market Overview, published in February 2005 and nearly 300 pages in length, provides insight into the trends and issues affecting the market. This Pharmacy Benefit Management Market Overview also identifies more than 50 of the leading market participants and provides a brief profile on each company, which includes (when available): the company background, strategy, products and services, financial and statistical information, and recent activities.

Topics Covered

Industry Overview/Trends

PBM List by Covered Lives

ACS State Healthcare

Aetna Pharmacy Management

AmeriHealth Mercy

AmeriScript

Anthem Prescription Management

Argus Health Systems

BeneCard Services

BeneScript Services

Caremark Rx

CBCA Rx

CIGNA HealthCare/RxPRIME

PharmaCare Management Services

Envision Pharmaceutical Services

Express Scripts

First Health Services Corporation

4D Pharmacy Management

HealthExtras/Catalyst Rx

Health Information Designs

Health Net Pharmaceutical Services

HealthTrans

Kroger Prescription Plans

MaxorPlus

Managed Pharmacy Benefits/Medicine Shoppe

MedImpact Healthcare Systems

Medco Health Solutions

MIM/Scrip Solutions

Navitus Health Solutions

NBRx

New Benefits

NMHCRX

Northwest Pharmacy Services

Partners Rx Management

PBM Plus

Pequot Pharmaceutical Network

Pharmaceutical Care Network

Pharmaceutical Technologies/NPS

Pharmacy Services Group

Prescription Solutions

Prime Therapeutics

RESTAT

RxAmerica

RxStrategies

RxWest

Safeway-SMCRx

Serve You Custom Prescription Management

Systems Xcellence

Total Script

US Script

Walgreens Health Initiatives

WebMD Prescription Benefit Solutions

WellPoint Pharmacy Management

Sources

Summary

Our Pharmacy Benefit Management (PBM) Market Overview provides the information and analysis you need to gain an understanding of the PBM market and the trends which affect it. Our PBM Market Overview also identifies approximately 40 market participants and provides information on each company which includes (when available): company background, company strategy, products and services, financial and statistical information and recent activities.

For more information visit http://www.researchandmarkets.com/reports/c31478